About the Intravitreal Chemotherapy Session
Intravitreal chemotherapy, a cutting-edge approach in cancer research, involves the direct delivery of anticancer drugs into the vitreous cavity of the eye. This method is primarily utilized in the treatment of intraocular malignancies like retinoblastoma and uveal melanoma. By bypassing systemic circulation, intravitreal chemotherapy minimizes systemic side effects while maximizing drug concentration at the tumor site, enhancing therapeutic efficacy. Additionally, it offers a promising alternative when conventional therapies such as radiation or surgery are contraindicated or ineffective. Despite its potential, challenges such as drug toxicity and the risk of ocular complications persist, necessitating further refinement and clinical investigation. Nonetheless, intravitreal chemotherapy stands as a beacon of hope, showcasing the relentless pursuit of innovative strategies to combat cancer while preserving ocular function and quality of life.
Topics Covered in Intravitreal Chemotherapy
Retinoblastoma Seeding
Vitreoretinal Lymphoma
Safety-Enhanced Injection
Ocular Pharmacokinetics
Retinal Toxicity
Intra-Arterial Chemotherapy
Related Scientific Sessions at CIOC 2027
Why Attend the Intravitreal Chemotherapy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Intravitreal Chemotherapy work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Intravitreal Chemotherapy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Intravitreal Chemotherapy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Intravitreal Chemotherapy Conference 2027 — FAQs
What is the Intravitreal Chemotherapy track at CIOC 2027?
The Intravitreal Chemotherapy track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Intravitreal Chemotherapy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Intravitreal Chemotherapy sessions?
Cancer researchers and clinicians, educators and students with an interest in Intravitreal Chemotherapy are all welcome — whether presenting or attending.
Can I present my research in the Intravitreal Chemotherapy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Intravitreal Chemotherapy sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Intravitreal Chemotherapy track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.